Exchange: OTC·Updated 10:18 AM EDT

ORGSOrgenesis Inc

$0.40
$0.095
(19.19%)
Today
Reported EarningsNov 13
Mkt Cap$4.85M
Vol100.00

About

Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies and services in the cell and gene therapy industry. It operates through the following segments: Octomera and Therapies. The Octomera segment refers to the point-of-care services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
Sector:
Technology Services
Industry:
Packaged Software
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Orgenesis Inc?
What is the 52-week high for Orgenesis Inc?
What is the 52-week low for Orgenesis Inc?
What is Orgenesis Inc stock price today?
What was Orgenesis Inc stock price yesterday?
What is the 50-day moving average of Orgenesis Inc?

Latest ORGS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.